Treatment of B16F10 (Fig. 3B) and LP07 cells (Fig. 4A) with the AC5 inhibitor reduced forskolin-induced cAMP production (P < 0.01), demonstrating its ability to block endogenous AC in these tumor cells. Here, ASAH1 is linked to neoplasm.